#BEGIN_DRUGCARD DB01775

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
96-26-4

# ChEBI_ID:
16016

# Chemical_Formula:
C3H6O3

# Chemical_IUPAC_Name:
1,3-dihydroxypropan-2-one

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
A ketotriose compound. Its addition to blood preservation solutions results in better maintenance of 2,3-diphosphoglycerate levels during storage. It is readily phosphorylated to dihydroxyacetone phosphate by triokinase in erythrocytes. In combination with naphthoquinones it acts as a sunscreening agent. [PubChem]

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
13706567	GOLDMAN L, WITTGENSTEIN E, BLANEY D, GOLDMAN J, SAWYER F: Studies of some physical properties of the dihydroxyacetone color complex. J Invest Dermatol. 1961 Apr;36:233-4.
13845496	WITTGENSTEIN E, BERRY HK: Staining of skin with dihydroxyacetone. Science. 1960 Sep 30;132:894-5.
14007781	WITTGENSTEIN E, GUEST GM: Biochemical effects of dihydroxyacetone. J Invest Dermatol. 1961 Nov;37:421-6.

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Dihydroxyacetone

# HET_ID:
2HA

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C3H6O3/c4-1-3(6)2-5/h4-5H,1-2H2

# InChI_Key:
InChIKey=RXKJFZQQPQGTFL-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C00184

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
1775

# Mechanism_Of_Action:
Not Available

# Melting_Point:
90 Â°C

# Molecular_Weight_Avg:
90.0779

# Molecular_Weight_Mono:
90.031694058

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1UN9

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.6

# Predicted_LogS:
0.97

# Predicted_Water_Solubility:
8.38e+02 g/l

# Primary_Accession_No:
DB01775

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
670

# PubChem_Substance_ID:
46505965

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00122

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OCC(=O)CO

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:29 -0700

# Wikipedia_Link:
http://en.wikipedia.org/wiki/Dihydroxyacetone

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
U09771

# Drug_Target_1_GenBank_ID_Protein:
493083

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
dhaK

# Drug_Target_1_Gene_Sequence:
>1659 bp
TTAGCCCAGCTCACTCTCCGCTAGCGCTTTAAACACCATCGCTAGGCGCTGCGCGCCGGG
GTCCATATTTCCGAGCAGGCTTTCGCTGCTCAGATACGATGCGCGACCCGCATTGGCTTT
GCTCGACAAACAGGTTCGTTCGGCTCCCGCTTGCGCGGCGTCGAATGCGGCCTGCAGATT
TTTCGGCTGTGCGAGCAGCGAGGTCAGGGCCGGTTGCAGCGCATCAATCATCGTGCGATC
GCCTTCGTCTGCGCCGCCGTAGAACTTCATCTGCGCCAGCCCCGTATTTAGCGCTTCGAC
AACGTTAGCGCCCTGTTCCAGTTTCTGCCCGGCGGCGGTAAAGAAGATTGACATCAGCAC
ACCGCTGGAACCGCCCATCACCACGGTCAGACGTTCGCCAATCAGCGCGAACAGCGTGGC
AAGGTTATTCAGCGGCAGCTGCTGGCGATGCAGCAGGCTGGCAATTTCACGCGCCGCGGC
GGCAAAGGTCGAACCGGTATCGCCATCGCCGACTTTGGCGTCCAGCGCATTCAGATGAGT
CTCCAGATCGGAAAGGGTTGCGGTGACCAGCTCCACAATCCCGGCCACCAGGGCGTTTGC
CGAAGGCTGGAATTCCACGCGGGCGCTAGCGTGAGATGACACTACGCAGGTGATTTCACG
CGGTGGGACCGGCGTCGGCCAGTTGCTGGTTTCCACTTCGGTGAGCAGTGCTTTTTCGAT
GCTCTCTTCCAGCACGATGGCCGTCAGTGAGAAGCCTTTCATATCCAGCGCGGTGACCAG
CGAGGCCGGGCCAATTAGCCAGTCGATACGCGAGTGCAGCGGGCTGCTGGCGAGTTCGCG
GGTGATGATGGCCATTTCGGCCACGGAAACGCCGCCAAGATTATTAATCATCACCGCCAG
ACGACCGGTTTCAGGCAGGGCGGCCAGCAGTTTATCCACCATCAGGTTTACCACTTGCGC
ACTGTTTTGGGTGTCGATAACCGATGCGCCTGGTTCGCCGTGAATTCCCATACCCAGCTC
CGCATGACCCGGATGATGACGAGGGGCTGCGTCGGTTTCTTGCGGCAGATGACAGCTGGA
AAGCGCTACGCCCAGGCTAAAGGTGTTGCTGGCTGCGTACTGCGCTTCACGCAGGACGGT
GGCGAGGTTATAGCCGCGTTCGGCAAAATAGCCTGCGATTTTATGCACCAGGATAGTTCC
CGCAATGCCACGTGGGTGTTTGTTATCCGGCAGGGAGATGTCGTCGCCGACAATCAGCAT
TTCAACGTTATAGCCAAGGCGACGCGCCTTCTCGGCGGCGAGACCGAAATTAAGACGGTC
ACCGGTGTAGTTTTTCACAATCAACAAACAGCCAGCCTCACCGGTCACCGCCTGAATCGC
GGTCAGTACAGCATCCACGCTCGGGGAGGCGAAAACGTCGCCGCAGACCGCAGCGGTTAG
CATGCCTTTACCGATAAACCCAACGTGCGCGGGTTCGTGTCCCGAACCGCCGCCGGAAAT
GACCGCTACGTTATTTTTATTAAGGTCACGACGGACCACGATGCGAATGGCCGGATCGCT
TTCCAGACGCGCCAGGTTATTCCATGGGCTGGCGATAATCGCCCCGTCGATGACGTCGCT
CACAAGATGGGTGCGTTGGTTAAAAAAGAATTGAGACAT

# Drug_Target_1_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_1_General_References:
Not Available

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2397

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
57941

# Drug_Target_1_Name:
Dihydroxyacetone kinase

# Drug_Target_1_Number_of_Residues:
552

# Drug_Target_1_PDB_ID:
1UN8

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF02733	Dak1
PF02734	Dak2

# Drug_Target_1_Protein_Sequence:
>Dihydroxyacetone kinase
MSQFFFNQRTHLVSDVIDGAIIASPWNNLARLESDPAIRIVVRRDLNKNNVAVISGGGSG
HEPAHVGFIGKGMLTAAVCGDVFASPSVDAVLTAIQAVTGEAGCLLIVKNYTGDRLNFGL
AAEKARRLGYNVEMLIVGDDISLPDNKHPRGIAGTILVHKIAGYFAERGYNLATVLREAQ
YAASNTFSLGVALSSCHLPQETDAAPRHHPGHAELGMGIHGEPGASVIDTQNSAQVVNLM
VDKLLAALPETGRLAVMINNLGGVSVAEMAIITRELASSPLHSRIDWLIGPASLVTALDM
KGFSLTAIVLEESIEKALLTEVETSNWPTPVPPREITCVVSSHASARVEFQPSANALVAG
IVELVTATLSDLETHLNALDAKVGDGDTGSTFAAAAREIASLLHRQQLPLNNLATLFALI
GERLTVVMGGSSGVLMSIFFTAAGQKLEQGANVVEALNTGLAQMKFYGGADEGDRTMIDA
LQPALTSLLAQPKNLQAAFDAAQAGAERTCLSSKANAGRASYLSSESLLGNMDPGAQRLA
MVFKALAESELG

# Drug_Target_1_Reaction:
ATP + glycerone = ADP + glycerone phosphate

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Catalyzes the phosphorylation of dihydroxyacetone

# Drug_Target_1_SwissProt_ID:
P45510

# Drug_Target_1_SwissProt_Name:
DHAK_CITFR

# Drug_Target_1_Synonyms:
DHA kinase
EC 2.7.1.29
Glycerone kinase

# Drug_Target_1_Theoretical_pI:
5.29

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB01775
